Response to Letter: 'Reply to "High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?"'. (14th September 2020) - Pineton de Chambrun, M.
Abstract : Click here to view the Letter to the Editor by Pineton de Chambrun et al.